Lenz Therapeutics has earned the FDA’s go-ahead for its aceclidine eye drop to crack the large presbyopia market, where past ...

Vertiv Holdings (NYSE:VRT) on Monday was rated Outperform in new research coverage by analysts at investment firm William ...

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) reported upbeat second-quarter earnings and 2025 guidance on Thursday. The company ...

Despite the overall decline in commercial product revenue, Moderna was also pleasantly surprised by Q2 Spikevax sales, which ...

We continue to feel confident about our ability to capture 90%," LPL CEO Rich Steinmeier told analysts during the firm's 2nd ...

In addition, The Allstate Corporation (NYSE:ALL) is taking advantage of a far better auto loss environment and employing ...

Jed Dorsheimer, William Blair analyst, joins 'The Exchange' to discuss Tesla's chip deal with Samsung and what it means for ...

William Blair is increasingly known for its prominence in the asset management business, with a global footprint of more than $81.9 billion¹ in client assets as of December 31, 2018.

William Blair is the premier global boutique with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to ...

William Blair has named Brent Gledhill as CEO. He will be succeeding John Ettelson, who has been appointed William Blair’s chairman. Gledhill joined William Blair as an investment banker in ...

Palo Alto Networks, Inc. (NASDAQ:PANW) is one of the best long term low volatility stocks to buy now. On July 16, William ...

William Blair wouldn’t immediately say how many total bankers it has currently, but that figure was 370 worldwide as of April 2019, so the reduction relative to that past banker headcount would ...